SCHEMBL5509385

SCHEMBL5509385

CCOc1ccc(F)c(C(=O)Nc2ccccc2)c1F

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 3/20 0.53
KMT2A Q03164 6/20 0.50
MEN1 O00255 5/20 0.50
MAPT P10636 5/20 0.49
RAB9A P51151 3/20 0.48
SMN1; SMN2 Q16637 4/20 0.47
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 2/20 0.46
HPGD P15428 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.45
NPC1 O15118 3/20 0.45
KCNK3 O14649 1/20 0.45
KCNK9 Q9NPC2 1/20 0.45
LMNA P02545 2/20 0.44
HTT P42858 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
BRAF P15056 1/20 0.44
CREBBP Q92793 1/20 0.44
NFKB1 P19838 1/20 0.44
NFKB2 Q00653 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4398112 0.79 TSHR (0.45) GAARAB9ASMN1; SMN2KDM4EALDH1A1
SCHEMBL4398448 0.77 L3MBTL1 (0.40) GAARAB9ASMN1; SMN2KDM4EL3MBTL1
SCHEMBL19793350 0.76 GAA (0.47) GAAKMT2AMEN1MAPTRAB9A
SCHEMBL31609727 0.75 MAPK1 (0.46) KMT2AMEN1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL22339324 0.75 MEN1 (0.56) GAAKMT2AMEN1MAPTRAB9A
SCHEMBL30739610 0.74 GAA (0.62) GAAKMT2AMEN1RAB9ANPC1
SCHEMBL20051587 0.74 GAA (0.62) GAAKMT2AMEN1RAB9ANPC1
SCHEMBL5504642 0.74 MEN1 (0.83) GAAKMT2AMEN1MAPTRAB9A
SCHEMBL30739749 0.72 JAK2 (0.71) GAAKMT2AMEN1RAB9ASMN1; SMN2
SCHEMBL10683473 0.71 RXFP1 (0.51) GAAKMT2AMEN1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1807078-A1 DIAMINOALKANE ASPARTIC PROTEASE INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2007-07-18 EP disclosed
WO-2006042150-A1 DIAMINOALKANE ASPARTIC PROTEASE INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2006-04-20 WO disclosed